Article History
Received: 20 November 2024
Accepted: 4 December 2024
First Online: 28 December 2024
Declarations
:
: Prof. Dong Keon Yon reports being funded by the GCS to conduct clinical trials in collaboration with Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM). No other potential conflict of interest relevant to this article was reported.
: This study was approved by the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM; IRB number, 2021-A02451-40) and was registered in the ClinicalTrials (identifier number, NCT05215054). This study adhered to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all patients.